Lataa...
Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
INTRODUCTION: The myelodysplastic syndromes (MDS) are a very heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increase risk of transformation to acute myeloid leukemia (AML). Daunorubicin (DNR) is an indispensable drug for the treatment of MDS and AML. Howeve...
Tallennettuna:
| Julkaisussa: | Int J Nanomedicine |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988587/ https://ncbi.nlm.nih.gov/pubmed/32021192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S233395 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|